NEW YORK: Health officials in the United states are warning of an increase in rare bacterial illnesses than can lead to meningitis and possible death.
The Centers for Disease Control and Prevention (CDC) issued a warning to US healthcare providers on Thursday concerning a rise in cases of invasive meningococcal disease, predominantly attributed to a specific strain of bacteria.
In the past year, the United States recorded 422 cases of this particular illness — the highest number since 2014. Already this year, 143 cases have been reported, indicating a trajectory likely to surpass the figures from 2023, according to the CDC. While most cases last year did not result in meningitis, at least 17 fatalities were reported. The incidence of cases was notably higher among adults aged 30 to 60, Black individuals, and those living with HIV, the CDC noted.
The bacteria responsible can trigger meningitis, a serious inflammation of the brain and spinal cord, manifesting symptoms such as fever, headache, neck stiffness, nausea, and vomiting. Additionally, it can cause bloodstream infections characterized by symptoms like chills, fatigue, cold extremities, rapid breathing, diarrhea, or, in later stages, a distinctive dark purple rash.
Although antibiotics can treat the infection, prompt intervention is crucial. Approximately 10% to 15% of infected individuals succumb to the illness, and survivors may experience complications such as deafness or limb amputations. Vaccines against meningococcal disease are also available.
Health officials recommend that all children receive a meningococcal conjugate vaccine, offering protection against the emerging strain, typically administered around middle school entry. Due to the waning effectiveness of vaccine immunity, the CDC further advises a booster dose at age 16. Additionally, vaccination is recommended for individuals at elevated risk, including those residing in outbreak-prone areas or those with HIV infection or specific underlying health conditions.
